Cellectis (CLLS) Non-Current Assets (2013 - 2026)

Cellectis' (CLLS) quarterly Non-Current Assets came in at $84.6 million in Q1 2026, down 8.26% year-on-year from $92.3 million in Q1 2025, and down 4.34% quarter-over-quarter from $88.5 million in Q4 2025.

Cellectis (CLLS) Non-Current Assets (2013 - 2026) Analysis & Trends

Cellectis' Non-Current Assets history runs 14 years deep, the most recent figure standing at $84.6 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 8.26% year-over-year to $84.6 million in Q1 2026; TTM through Mar 2026 was $84.6 million, a 8.26% decrease from a year earlier, with the FY2025 full-year figure at $88.5 million, down 8.29% from the prior year.
  • Non-Current Assets eased to $84.6 million in Q1 2026 per CLLS's latest filing, from $88.5 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $152.0 million in Q1 2022 and bottomed at $84.6 million in Q1 2026.
  • The 5-year median for Non-Current Assets is $113.2 million (2023), against an average of $112.0 million.
  • Across the five-year window, Non-Current Assets decreased 25.05% in 2022 and rose 21.69% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at $117.4 million in 2022, then slipped by 13.75% to $101.3 million in 2023, then retreated by 4.73% to $96.5 million in 2024, then declined by 8.29% to $88.5 million in 2025, then declined by 4.34% to $84.6 million in 2026.
  • Per Business Quant, the three latest CLLS Non-Current Assets figures stand at $84.6 million (Q1 2026), $88.5 million (Q4 2025), and $121.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 21.65 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 5.83 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.95 Bn
4 NuCana 279.75 Bn 279.75 Bn - 3.95 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 14.75 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 22.66 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 285.82 Mn
10 Cellectis 281.48 Mn 95.81 Mn - 84.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 84.64 Mn
Dec 31, 2025 88.48 Mn
Sep 30, 2025 121.85 Mn
Jun 30, 2025 123.33 Mn
Mar 31, 2025 92.26 Mn
Dec 31, 2024 96.48 Mn
Sep 30, 2024 101.45 Mn
Jun 30, 2024 101.34 Mn
Mar 31, 2024 96.39 Mn
Dec 31, 2023 101.27 Mn
Sep 30, 2023 113.21 Mn
Jun 30, 2023 114.39 Mn
Mar 31, 2023 114.04 Mn
Dec 31, 2022 117.41 Mn
Sep 30, 2022 139.31 Mn
Jun 30, 2022 145.72 Mn
Mar 31, 2022 152.02 Mn
Dec 31, 2021 156.65 Mn
Sep 30, 2021 177.04 Mn
Jun 30, 2021 177.21 Mn